Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Medical guidelines

Vol. 150 No. 3940 (2020)

Candida auris – recommendations on infection prevention and control measures in Switzerland

DOI
https://doi.org/10.4414/smw.2020.20297
Cite this as:
Swiss Med Wkly. 2020;150:w20297
Published
25.09.2020

Summary

Candida auris, a globally emerging pathogen, has been repeatedly introduced into European healthcare settings, leading to large and long-lasting nosocomial outbreaks. The pathogen has already been isolated in Switzerland, requiring clinicians and microbiologists to become alert. This is the first comprehensive guidance document on prevention and control of C. auris in Swiss acute care hospitals. It brings to light the most recent evidence from published original articles and reviews. We emphasise the importance of quickly identifying this yeast by means of screening in order to prevent an outbreak that could be difficult to contain. Key containment strategies include reinforcing early detection, hand hygiene, application of strict contact precautions for colonised and infected patients, and thorough specific environmental cleaning and disinfection.

References

  1. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–4. doi:.https://doi.org/10.1111/j.1348-0421.2008.00083.x
  2. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2017;64(2):134–40. doi:.https://doi.org/10.1093/cid/ciw691
  3. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5(35):35. doi:.https://doi.org/10.1186/s13756-016-0132-5
  4. Ruiz-Gaitán A, Moret AM, Tasias-Pitarch M, Aleixandre-López AI, Martínez-Morel H, Calabuig E, et al. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital. Mycoses. 2018;61(7):498–505. doi:.https://doi.org/10.1111/myc.12781
  5. Eyre DW, Sheppard AE, Madder H, Moir I, Moroney R, Quan TP, et al. A Candida auris Outbreak and Its Control in an Intensive Care Setting. N Engl J Med. 2018;379(14):1322–31. doi:.https://doi.org/10.1056/NEJMoa1714373
  6. Biswal M, Rudramurthy SM, Jain N, Shamanth AS, Sharma D, Jain K, et al. Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions. J Hosp Infect. 2017;97(4):363–70. doi:.https://doi.org/10.1016/j.jhin.2017.09.009
  7. Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface. J Clin Microbiol. 2017;55(10):2996–3005. doi:.https://doi.org/10.1128/JCM.00921-17
  8. Piedrahita CT, Cadnum JL, Jencson AL, Shaikh AA, Ghannoum MA, Donskey CJ. Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species. Infect Control Hosp Epidemiol. 2017;38(9):1107–9. doi:.https://doi.org/10.1017/ice.2017.127
  9. A misterious infection, spanning the globe in a climate of secrecy. New York Times. [Internet]. Available at: https://www.nytimes.com/2019/04/06/health/drug-resistant-candida-auris.html. Accessed 2019 June 11.
  10. Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, et al. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother. 2018;73(4):891–9. doi:.https://doi.org/10.1093/jac/dkx480
  11. Zhu Y, O’Brien B, Leach L, Clarke A, Bates M, Adams E, et al. Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned. J Clin Microbiol. 2020;58(4):e01503-19. doi:.https://doi.org/10.1128/JCM.01503-19
  12. Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013;19(10):1670–3. doi:.https://doi.org/10.3201/eid1910.130393
  13. Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, et al.; Candida auris Incident Management Team. Candida auris: a Review of the Literature. Clin Microbiol Rev. 2017;31(1):e00029-17. doi:.https://doi.org/10.1128/CMR.00029-17
  14. Riat A, Neofytos D, Coste A, Harbarth S, Bizzini A, Grandbastien B, et al. First case of Candida auris in Switzerland: discussion about preventive strategies. Swiss Med Wkly. 2018;148:w14622.
  15. Centers for Disease Control and Prevention (CDC). Clinical alert to U.S. healthcare facilities: global emergence of invasive infections caused by the multidrug-resistant yeast Candida auris. Atlanta: CDC; Update September 18 2017. Available at: https://www.cdc.gov/fungal/candida-auris/c-auris-alert-09-17.html.
  16. European Centre for Disease Prevention and Control (ECDC). Candida auris in healthcare settings -Europe. Stockholm: ECDC; 2016. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Candida-in-healthcaresettings_19-Dec-2016.pdf.
  17. Public Health England (PHE). Candida auris within the United Kingdom: updated guidance published. Updated 11 August 2017. Available from https://www.gov.uk/government/publications/candida-auris-emergence-in-england/candida-auris-within-the-united-kingdom-updated-guidance-published. Accessed 2020 May 7.
  18. Pan American Health Organization / World Health Organization. Epidemiological Alert: Candida auris outbreaks in health care services. 3 October, Washington, D.C.: PAHO/WHO; 2016; available at www.paho.org. Accessed 2019 June 14.
  19. Ontario Agency for Health Protection and Promotion (Public Health Ontario), Provincial Infectious Diseases Advisory Committee. Interim guide for infection prevention and control of Candida auris. Toronto, ON: Queen's Printer for Ontario; 2019. Available from: www.publichealthontario.ca. Accessed 2019 June 14.
  20. Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care. 2018;6(1):69. doi:.https://doi.org/10.1186/s40560-018-0342-4
  21. Centers for Disease Control and Prevention (CDC). Atlanta. Tracking C. auris. Available from: https://www.cdc.gov/fungal/diseases/candidiasis/tracking-c-auris.html. Accessed 2020 May 7.
  22. Kohlenberg A, Struelens MJ, Monnet DL, Plachouras D ; The Candida Auris Survey Collaborative Group. Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017. Euro Surveill. 2018;23(13):pii=18-00136. doi:.https://doi.org/10.2807/1560-7917.ES.2018.23.13.18-00136
  23. Plachouras D, Lötsch F, Kohlenberg A, Monnet DL ; Candida auris survey collaborative group. Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019. Euro Surveill. 2020;25(12):pii=2000240. doi:.https://doi.org/10.2807/1560-7917.ES.2020.25.12.2000240
  24. WHO Guidelines on Hand Hygiene in Health. Care First Global Patient Safety Challenge Clean Care is Safer Care, 2009. Available from: https://www.who.int/gpsc/5may/background/5moments/en/. Accessed 2019 Feb 15.
  25. Vazquez JA, Dembry LM, Sanchez V, Vazquez MA, Sobel JD, Dmuchowski C, et al. Nosocomial Candida glabrata colonization: an epidemiologic study. J Clin Microbiol. 1998;36(2):421–6. doi:.https://doi.org/10.1128/JCM.36.2.421-426.1998
  26. Strausbaugh LJ, Sewell DL, Ward TT, Pfaller MA, Heitzman T, Tjoelker R. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol. 1994;32(9):2299–300. doi:.https://doi.org/10.1128/JCM.32.9.2299-2300.1994
  27. Kenters N, Kiernan M, Chowdhary A, Denning DW, Pemán J, Saris K, et al. Control of Candida auris in healthcare institutions. Outcome of an International Society for Antimicrobial Chemotherapy expert meeting. Int J Antimicrob Agents. 2019;54(4):400–6. doi:.https://doi.org/10.1016/j.ijantimicag.2019.08.013
  28. Tsay S, Kallen A, Jackson BR, Chiller TM, Vallabhaneni S. Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast. Clin Infect Dis. 2018;66(2):306–11. doi:.https://doi.org/10.1093/cid/cix744
  29. Martischang R, Buetti N, Balmelli C, Saam M, Widmer A, Harbarth S. Nation-wide survey of screening practices to detect carriers of multi-drug resistant organisms upon admission to Swiss healthcare institutions. Antimicrob Resist Infect Control. 2019;8(1):37. doi:.https://doi.org/10.1186/s13756-019-0479-5
  30. Vogelzang EH, Weersink AJL, van Mansfeld R, Chow NA, Meis JF, van Dijk K. The First Two Cases of Candida auris in The Netherlands. J Fungi (Basel). 2019;5(4):91. doi:.https://doi.org/10.3390/jof5040091
  31. European Centre for Disease Prevention and Control. Candida auris in healthcare settings – Europe – first update, 23 April 2018. Stockholm: ECDC; 2018.
  32. Centers for Disease Control and Prevention. Surveillance for Candida auris. December 21, 2018. Available from: https://www.cdc.gov/fungal/candida-auris/c-auris-surveillance.html. Accessed 2019 August 30.
  33. Dewaele K, Lagrou K, Frans J, Hayette MP, Vernelen K. Hospital Laboratory Survey for Identification of Candida auris in Belgium. J Fungi (Basel). 2019;5(3):84. doi:.https://doi.org/10.3390/jof5030084
  34. Buil JB, van der Lee HAL, Curfs-Breuker I, Verweij PE, Meis JF. External Quality Assessment Evaluating the Ability of Dutch Clinical Microbiological Laboratories to Identify Candida auris. J Fungi (Basel). 2019;5(4):94. doi:.https://doi.org/10.3390/jof5040094
  35. Chowdhary A, Sharma C, Meis JF. Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 2017;13(5):e1006290. doi:.https://doi.org/10.1371/journal.ppat.1006290
  36. Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris. J Clin Microbiol. 2017;55(8):2445–52. doi:.https://doi.org/10.1128/JCM.00630-17
  37. Leach L, Zhu Y, Chaturvedi S. Development and Validation of a Real-Time PCR Assay for Rapid Detection of Candida auris from Surveillance Samples. J Clin Microbiol. 2018;56(2):e01223-17. doi:.https://doi.org/10.1128/JCM.01223-17
  38. Tsay S, Welsh RM, Adams EH, Chow NA, Gade L, Berkow EL, et al.; MSD. Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities - United States, June 2016-May 2017. MMWR Morb Mortal Wkly Rep. 2017;66(19):514–5. doi:.https://doi.org/10.15585/mmwr.mm6619a7
  39. Cadnum JL, Shaikh AA, Piedrahita CT, Sankar T, Jencson AL, Larkin EL, et al. Effectiveness of disinfectants against candida auris and other candida species. Infect Control Hosp Epidemiol. 2017;38(10):1240–3. doi:.https://doi.org/10.1017/ice.2017.162
  40. Rutala WA, Kanamori H, Gergen MF, Sickbert-Bennett EE, Weber DJ. Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities. Infect Control Hosp Epidemiol. 2019;40(3):380–2. doi:.https://doi.org/10.1017/ice.2019.1
  41. Cadnum JL, Shaikh AA, Piedrahita CT, Jencson AL, Larkin EL, Ghannoum MA, et al. Relative resistance of the emerging fungal pathogen Candida auris and other Candida species to killing by ultraviolet light. Infect Control Hosp Epidemiol. 2018;39(1):94–6. doi:.https://doi.org/10.1017/ice.2017.239
  42. de Groot T, Chowdhary A, Meis JF, Voss A. Killing of Candida auris by UV-C: Importance of exposure time and distance. Mycoses. 2019;62(5):408–12. doi:.https://doi.org/10.1111/myc.12903
  43. Schlegel M, Oswald E. Minimale Standards für den Umgang mit Schmutzwäsche im Gesundheitswesen. Available from: https://www.sgsh.ch/fileadmin/user_upload/Fachwissen/Dokumente/17-04_SGSH_VTS_Empfehlung_zum_Umgang_mit_Schmutzwaesche_def.pdf. Accessed, 2019 September 27.
  44. Abdolrasouli A, Armstrong-James D, Ryan L, Schelenz S. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris. Mycoses. 2017;60(11):758–63. doi:.https://doi.org/10.1111/myc.12699
  45. Moore G, Schelenz S, Borman AM, Johnson EM, Brown CS. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris. J Hosp Infect. 2017;97(4):371–5. doi:.https://doi.org/10.1016/j.jhin.2017.08.019
  46. Huang SS, Septimus E, Hayden MK, Kleinman K, Sturtevant J, Avery TR, et al.; Agency for Healthcare Research and Quality (AHRQ) DEcIDE Network and Healthcare-Associated Infections Program, and the CDC Prevention Epicenters Program. Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: an analysis of a cluster-randomised trial. Lancet Infect Dis. 2016;16(1):70–9. doi:.https://doi.org/10.1016/S1473-3099(15)00238-8

Most read articles by the same author(s)

1 2 > >>